Endava price target raised to $33 from $31 at BofA

BofA raised the firm’s price target on Endava (DAVA) to $33 from $31 and keeps a Neutral rating on the shares. The firm cites an increase in comp group multiples for the target bump. However, given several quarters of “missed execution,” BofA continues to view Endava as a “show me story.”